Medication
Tretten
DIN 02389975 · Novo Nordisk Canada Inc
What it is
- Active ingredients
- Catridecacog — 2500 unit
- Form and route
- Powder For Solution · Intravenous
- Schedule
- SCHEDULE D
- Authorised since
- 2013-01-30
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
No other medication authorised in Canada shares this active ingredient.
Health Canada groups products by their active ingredients. No other marketed product shares this one’s group, which usually means it is still the only authorised version — not that alternatives were hidden or missed.
How it is classified
- Anatomical main group
- Blood and blood-forming organs
- ATC code
- B02BD11
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of B02BD11, see the WHO ATC/DDD Index.
Recalls and safety alerts
Recall matching is not available yet.
RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.